SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-012739
Filing Date
2023-08-01
Accepted
2023-08-01 16:27:09
Documents
61
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rytm-20230630x10q.htm   iXBRL 10-Q 1926227
2 EX-31.1 rytm-20230630xex31d1.htm EX-31.1 12985
3 EX-31.2 rytm-20230630xex31d2.htm EX-31.2 14727
4 EX-32.1 rytm-20230630xex32d1.htm EX-32.1 6982
5 EX-32.2 rytm-20230630xex32d2.htm EX-32.2 8076
  Complete submission text file 0001558370-23-012739.txt   6761279

Data Files

Seq Description Document Type Size
6 EX-101.SCH rytm-20230630.xsd EX-101.SCH 41186
7 EX-101.CAL rytm-20230630_cal.xml EX-101.CAL 55975
8 EX-101.DEF rytm-20230630_def.xml EX-101.DEF 159143
9 EX-101.LAB rytm-20230630_lab.xml EX-101.LAB 402158
10 EX-101.PRE rytm-20230630_pre.xml EX-101.PRE 278075
55 EXTRACTED XBRL INSTANCE DOCUMENT rytm-20230630x10q_htm.xml XML 1026163
Mailing Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Filer) CIK: 0001649904 (see all company filings)

IRS No.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38223 | Film No.: 231132118
SIC: 2834 Pharmaceutical Preparations